Literature DB >> 29236635

Rosai-Dorfman Disease with Activating KRAS Mutation - Response to Cobimetinib.

Eric Jacobsen1, Vignesh Shanmugam2, Jyothi Jagannathan3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29236635     DOI： 10.1056/NEJMc1713676

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

Review 1.  Imaging of Histiocytosis in the Era of Genomic Medicine.

Authors:  Hyesun Park; Mizuki Nishino; Jason L Hornick; Eric D Jacobsen
Journal:  Radiographics       Date:  2018-11-30       Impact factor: 5.333

2.  An avatar for precision cancer therapy.

Authors:  Shumei Kato; Razelle Kurzrock
Journal:  Nat Biotechnol       Date:  2018-11-09       Impact factor: 54.908

Review 3.  Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Authors:  Matthias Papo; Fleur Cohen-Aubart; Ludovic Trefond; Adeline Bauvois; Zahir Amoura; Jean-François Emile; Julien Haroche
Journal:  Curr Oncol Rep       Date:  2019-05-21       Impact factor: 5.075

4.  Successful treatment of disseminated Rosai-Dorfman disease with siltuximab.

Authors:  Hannah Lee; Gentry King; Kavita Garg; Zenggang Pan; Jennifer Tobin; William A Robinson
Journal:  Haematologica       Date:  2018-03-29       Impact factor: 9.941

Review 5.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

6.  BRAF V600E mutation detected in a case of Rosai-Dorfman disease.

Authors:  Giancarlo Fatobene; Julien Haroche; Zofia Hélias-Rodzwicz; Frédéric Charlotte; Valérie Taly; Aliana Meneses Ferreira; André Néder Ramires Abdo; Vanderson Rocha; Jean-François Emile
Journal:  Haematologica       Date:  2018-05-10       Impact factor: 9.941

7.  Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up.

Authors:  Sonia Mahajan; Reiko Nakajima; Mariko Yabe; Ahmet Dogan; Gary A Ulaner; Joachim Yahalom; Ariela Noy; Eli L Diamond; Heiko Schöder
Journal:  Clin Nucl Med       Date:  2020-06       Impact factor: 7.794

8.  Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis.

Authors:  Filip Janku; Eli L Diamond; Aaron M Goodman; Vaijayanthi Kandadai Raghavan; Tamara G Barnes; Shumei Kato; Omar Abdel-Wahab; Benjamin H Durham; Funda Meric-Bernstam; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2019-04-23       Impact factor: 6.261

9.  Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL).

Authors:  Natalie Galanina; Razelle Kurzrock
Journal:  Cancer Biol Ther       Date:  2018-10-11       Impact factor: 4.742

Review 10.  Cancer of Unknown Primary in the Molecular Era.

Authors:  Shumei Kato; Ahmed Alsafar; Vighnesh Walavalkar; John Hainsworth; Razelle Kurzrock
Journal:  Trends Cancer       Date:  2021-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.